GOVX CIK: 832489

GeoVax Labs, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
28.9
FY23:
7.89
FY24:
7.93
FY25:
5.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.17
FY22:
2.41
FY23:
1.40
FY24:
0.22
FY25:
1.03
Total assets
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
31.3
FY23:
9.28
FY24:
8.16
FY25:
6.34

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
5.44
FY22:
4.75
FY23:
3.52
FY24:
3.11
FY25:
1.94
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.00
FY22:
0
FY23:
0
FY24:
0
FY25:
0.58
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.36
FY22:
26.6
FY23:
5.76
FY24:
5.05
FY25:
3.83
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
31.3
FY23:
9.28
FY24:
8.16
FY25:
6.34

All amounts in millions USD Data sources:SEC EDGARTwelve Data